Event Details
AmCham's Pharmaceutical Committee invites you to a discussion entitled Chronic and Autoimmune Diseases in the time of COVID-19 on Wednesday, October 20, 2021, from 10:00 AM to 11:30 AM.
โโ
The COVID-19 pandemic has adversely impacted almost every aspect of our society and none more so than the most vulnerable among usโindividuals with chronic and autoimmune diseases. Chronic and autoimmune diseases include Psoriasis, Multiple Sclerosis, Type 1 Diabetes, Ankylosing Spondylitis (AS), and many others. Most individuals with autoimmune diseases are already medically fragile and suffer from complex medical challenges. Furthermore, this population has not yet received the attention from society or the health sector that it requires, or deserves. Unfortunately, this has been exacerbated by the urgency and exponential increase of COVID-19 cases around the globe which has taken over the priorities of health care providers.
Even in the best of times, individuals with chronic and autoimmune diseases and their health workers report facing significant care inadequacies and unmet medical needs as a result of their illness. In a time where the country is facing a virulent pandemic, how can the private sector take part in ensuring that no one is left behind?